Molnar C, Stiteler C, Stachler E, Taylor A. In patients with hyperkalemia, does discontinuing a RAAS inhibitor have a clinical benefit?. Evidence-Based Practice 28(8):p 26-27, August 2025. | DOI: 10.1097/EBP.0000000000002426
Hess D, Grimes A, Dittmer A, Zou R, Ordons B. “Comparison of Efficacy and Safety of Heparin versus Enoxaparin for Pulmonary Embolism Treatment.” STFM Annual Meeting. Salt Lake City, Utah. May 3, 2025. [Abstract]
Stachler E, Grimes A, Proddutur B. “Frequency of DOAC Monitoring in Older Adults.” Presented at American Geriatrics Society Annual Meeting 2025. Chicago, IL. May 9, 2025. [Abstract]
Stachler E, Grimes A, Leman K. “Bisphosphonate Drug Holiday Duration.” Presented at American Geriatrics Society Annual Meeting 2025. Chicago, IL. May 9, 2025. [Abstract]
Marker ER, Grimes A, Leman K. Pharmacist-led intervention to improve osteoporosis treatment rates after hip fracture. UPMC Family Medicine Scholarship Day; Altoona, PA. May 17, 2024. [Poster]
Reigh AV, Proddutur B, and Grimes AE. Evaluating the impact of pharmacist-driven type 2 diabetes management on guideline-directed medications in older adults. UPMC Family Medicine Scholarship Day; Altoona, PA. May 17, 2024 [Poster]
Stachler E, Reigh A, Taylor A, Haugh A. Do patients with moderate-to-severe dementia experience less cognitive decline on memantine monotherapy than patients on both memantine and donepezil?. Evidence-Based Practice ():10.1097/EBP.0000000000002280, November 15, 2024. | DOI: 10.1097/EBP.0000000000002280
Kim G, Mohan E, Sakely H, Grimes A. “Deprescribing Aspirin for Primary Prevention of Cardiovascular Disease in Geriatric Patients” Presented at American Geriatrics Society Annual Meeting 2023. Long Beach, CA. May 5, 2023. [Abstract] poster award, 2nd place, Quality Improvement Category.